Regina Berkovich, MD, PhD

August 11, 2022

Drs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.

August 11, 2022

Experts in neurology explore the benefits of a collaborative care approach for patients with multiple sclerosis.

August 11, 2022

Regina Berkovich, MD, PhD, shares her approach on the initiation and cessation of treatment for patients with multiple sclerosis who are considering family planning and vaccinations.

August 04, 2022

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, provide an overview of the impact vaccinations and immunization may have on multiple sclerosis therapies, highlighting the ability of S1P treatments to remain effective.

August 04, 2022

Regina Berkovich, MD, PhD, provides insight on the considerations and patient awareness of the risk of infections with disease-modifying therapies in patients with multiple sclerosis.

July 28, 2022

Experts in neurology discuss the considerations and practicalities of treating patients with multiple sclerosis who may undergo surgery and explore the role of treatment holidays.

July 28, 2022

Regina Berkovich, MD, PhD, comments on the role of patient education in engaging ethnically diverse and underrepresented patient populations with multiple sclerosis in their treatment plans.

July 21, 2022

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, share advice for building trust and individualizing treatment approaches in ethnically diverse and underrepresented patient populations with multiple sclerosis.

July 21, 2022

Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, highlight the role of a multidisciplinary care team in engaging ethnically diverse and underrepresented patient populations with multiple sclerosis in clinical trials and practice.

July 14, 2022

Experts in neurology explore the awareness of multiple sclerosis in ethnically diverse and underrepresented patient populations, commenting on the need for greater clinical trial inclusion.